Concepedia

Publication | Open Access

DNASE1L3 as a Prognostic Biomarker Associated with Immune Cell Infiltration in Cancer

39

Citations

43

References

2021

Year

Abstract

DNASE1L3 has potential to serve as a prognostic biomarker in cancer of the breast, kidney, liver, stomach, lung adenocarcinoma and sarcoma. Down-regulation of DNASE1L3 may participate in immune escape via CCR7/CCL19 axis.

References

YearCitations

Page 1